Literature DB >> 22907814

Early control of Mycobacterium tuberculosis infection requires il12rb1 expression by rag1-dependent lineages.

Halli E Miller1, Richard T Robinson.   

Abstract

IL12RB1 is essential for human resistance to Mycobacterium tuberculosis infection. In the absence of a functional IL12RB1 allele, individuals exhibit susceptibility to disseminated, recurrent mycobacterial infections that are associated with defects in both RAG1-dependent and RAG1-independent hematopoietic lineages. Despite this well-established association, a causal relationship between M. tuberculosis susceptibility and IL12RB1 deficiency in either RAG1-dependent or RAG1-independent lineages has never been formally tested. Here, we use the low-dose aerosol model of experimental tuberculosis (TB) to both establish that infected il12rb1(-/-) mice recapitulate important aspects of TB in IL12RB1 null individuals and, more importantly, use radiation bone marrow chimeras to demonstrate that restriction of il12rb1 deficiency solely to rag1-dependent lineages (i.e., T and B cells) allows for the full transfer of the il12rb1(-/-) phenotype. We further demonstrate that the protection afforded by adaptive lymphocyte il12rb1 expression is mediated partially through ifng and that, within the same infection, il12rb1-sufficient T cells exhibit dominance over il12rb1-deficient T cells by enhancing ifng expression in the latter population. Collectively, our data establish a basic framework in which to understand how IL12RB1 promotes control of this significant human disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907814      PMCID: PMC3486065          DOI: 10.1128/IAI.00426-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  74 in total

1.  Functional STAT3 deficiency compromises the generation of human T follicular helper cells.

Authors:  Cindy S Ma; Danielle T Avery; Anna Chan; Marcel Batten; Jacinta Bustamante; Stephanie Boisson-Dupuis; Peter D Arkwright; Alexandra Y Kreins; Diana Averbuch; Dan Engelhard; Klaus Magdorf; Sara S Kilic; Yoshiyuki Minegishi; Shigeaki Nonoyama; Martyn A French; Sharon Choo; Joanne M Smart; Jane Peake; Melanie Wong; Paul Gray; Matthew C Cook; David A Fulcher; Jean-Laurent Casanova; Elissa K Deenick; Stuart G Tangye
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

2.  IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung.

Authors:  Shabaana A Khader; Lokesh Guglani; Javier Rangel-Moreno; Radha Gopal; Beth A Fallert Junecko; Jeffrey J Fountain; Cynthia Martino; John E Pearl; Michael Tighe; Yin-yao Lin; Samantha Slight; Jay K Kolls; Todd A Reinhart; Troy D Randall; Andrea M Cooper
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

3.  Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation.

Authors:  Nabil Bosco; Lee Kim Swee; Angèle Bénard; Rhodri Ceredig; Antonius Rolink
Journal:  Exp Hematol       Date:  2010-01-04       Impact factor: 3.084

4.  Memory CD4+ T cells induce innate responses independently of pathogen.

Authors:  Tara M Strutt; K Kai McKinstry; John P Dibble; Caylin Winchell; Yi Kuang; Jonathan D Curtis; Gail Huston; Richard W Dutton; Susan L Swain
Journal:  Nat Med       Date:  2010-05-02       Impact factor: 53.440

Review 5.  Tuberculosis: what we don't know can, and does, hurt us.

Authors:  David G Russell; Clifton E Barry; JoAnne L Flynn
Journal:  Science       Date:  2010-05-14       Impact factor: 47.728

6.  A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung.

Authors:  C D D'Souza; A M Cooper; A A Frank; S Ehlers; J Turner; A Bendelac; I M Orme
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

Review 7.  A review of murine models of latent tuberculosis infection.

Authors:  Changhong Shi; Jieran Shi; Zhikai Xu
Journal:  Scand J Infect Dis       Date:  2011-09-06

8.  IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1.

Authors:  Tonya D Russell; Qingyun Yan; Guangshun Fan; Anthony P Khalifah; D Keith Bishop; Steven L Brody; Michael J Walter
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

9.  Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration.

Authors:  Richard T Robinson; Shabaana A Khader; Cynthia A Martino; Jeffrey J Fountain; Maria Teixeira-Coelho; John E Pearl; Stephen T Smiley; Gary M Winslow; David L Woodland; Michael J Walter; Jose R Conejo-Garcia; Ueli Gubler; Andrea M Cooper
Journal:  J Exp Med       Date:  2010-03-08       Impact factor: 14.307

10.  What do we really know about how CD4 T cells control Mycobacterium tuberculosis?

Authors:  Egidio Torrado; Andrea M Cooper
Journal:  PLoS Pathog       Date:  2011-07-28       Impact factor: 6.823

View more
  15 in total

Review 1.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

2.  γ-herpesvirus latency attenuates Mycobacterium tuberculosis infection in mice.

Authors:  Halli E Miller; Kaitlin E Johnson; Vera L Tarakanova; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2019-04-30       Impact factor: 3.131

3.  IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.

Authors:  Allison E Reeme; Halli E Miller; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2013-03-13       Impact factor: 3.131

Review 4.  The Many Hosts of Mycobacteria 8 (MHM8): A conference report.

Authors:  Michelle H Larsen; Karen Lacourciere; Tina M Parker; Alison Kraigsley; Jacqueline M Achkar; Linda B Adams; Kathryn M Dupnik; Luanne Hall-Stoodley; Travis Hartman; Carly Kanipe; Sherry L Kurtz; Michele A Miller; Liliana C M Salvador; John S Spencer; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2020-02-11       Impact factor: 3.131

5.  IL12Rβ1ΔTM is a secreted product of il12rb1 that promotes control of extrapulmonary tuberculosis.

Authors:  Aurelie A Ray; Jeffrey J Fountain; Halli E Miller; Andrea M Cooper; Richard T Robinson
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

6.  Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.

Authors:  Schafiq Nabhani; Sebastian Ginzel; Hagit Miskin; Shoshana Revel-Vilk; Dan Harlev; Bernhard Fleckenstein; Andrea Hönscheid; Prasad T Oommen; Michaela Kuhlen; Ralf Thiele; Hans-Jürgen Laws; Arndt Borkhardt; Polina Stepensky; Ute Fischer
Journal:  Haematologica       Date:  2015-06-25       Impact factor: 9.941

Review 7.  In search of a new paradigm for protective immunity to TB.

Authors:  Cláudio Nunes-Alves; Matthew G Booty; Stephen M Carpenter; Pushpa Jayaraman; Alissa C Rothchild; Samuel M Behar
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

8.  Primary Role of Suppressor of Cytokine Signaling 1 in Mycobacterium bovis BCG Infection.

Authors:  Shogo Soma; Satoru Kawai; Hiroyasu Inada; Kenta Watanabe; Satoru Mizuno; Seiichi Kato; Kazuhiro Matsuo; Yasuhiro Yasutomi
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

9.  Functional Analysis of Immune Signature Genes in Th1* Memory Cells Links ISOC1 and Pyrimidine Metabolism to IFN-γ and IL-17 Production.

Authors:  Yulia Kushnareva; Ian T Mathews; Alexander Y Andreyev; Gokmen Altay; Cecilia S Lindestam Arlehamn; Vijayanand Pandurangan; Roland Nilsson; Mohit Jain; Alessandro Sette; Bjoern Peters; Sonia Sharma
Journal:  J Immunol       Date:  2021-02-05       Impact factor: 5.422

10.  Dietary Vitamin D3 Suppresses Pulmonary Immunopathology Associated with Late-Stage Tuberculosis in C3HeB/FeJ Mice.

Authors:  Allison E Reeme; Richard T Robinson
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.